Leaflet: information for the user
Lizifen 8.75 mg chewable tablets, honey and lemon flavor
flurbiprofen
Read this leaflet carefully before you start taking this medicine, as it contains important information for you.
Follow exactly the administration instructions contained in this leaflet or those given by your doctor, pharmacist or nurse.
1. What is Lizifen and what it is used for
2. What you need to know before starting to take Lizifen
3. How to take Lizifen
4. Possible side effects
5. Storage of Lizifen
6. Contents of the pack and additional information
Lizifen contains flurbiprofen. Flurbiprofen belongs to a group of medications called nonsteroidal anti-inflammatory drugs (NSAIDs). These medications act by modifying the body's response to pain, swelling, and fever.
Lizifen is used for the short-term relief of symptoms of sore throat such as pain, difficulty swallowing, and inflammation in adults and adolescents 12 years of age and older.
You should consult a doctor if symptoms worsen or do not improve after 3 days of treatment.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Lizifen if you:
Avoid concomitant use of two or more NSAIDs or corticosteroids (such as celecoxib, ibuprofen, diclofenac sodium, or prednisolone), as this may increase the risk of adverse effects, particularly gastrointestinal events such as ulcers and bleeding (see section "Other medications and Lizifen”)
While takingLizifen
Children
This medication cannot be used by children under 12 years old
Other medications and Lizifen
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take another medication. In particular, if you are taking:
Lizifen with food, drinks, and alcohol
Avoid consuming alcohol during treatment with Lizifen, as it may increase the risk of gastrointestinal bleeding
Pregnancy, breastfeeding, and fertility
The oral forms (such as tablets) of flurbiprofen may cause adverse effects in unborn babies. It is unknown if the same risk exists with Lizifen
Do not take this medication if you are in the last 3 months of pregnancy. If you are in the first 6 months of pregnancy or breastfeeding, consult your doctor before taking this medication. If you need treatment during this period, the lowest possible dose should be used for the shortest possible time
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication
Flurbiprofen belongs to a group of medications that may affect fertility in women. This effect is reversible when the medication is stopped. It is unlikely that occasional use of this medication will affect your chances of becoming pregnant, but inform your doctor before taking this medication if you have difficulty conceiving
Driving and operating machinery
No studies have been conducted on the effects on the ability to drive and operate machinery. However, if you experience adverse reactions such as dizziness and/or visual disturbances, do not drive or operate machinery
Lizifen contains isomalta, maltitol, and fragrances that contain allergens
This medication contains isomalta and maltitol. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication. It may cause a mild laxative effect. Caloric value: 2.3 kcal/g of maltitol/isomalta
This medication contains fragrances with d-limonene and geraniol
D-limonene and geraniol may cause allergic reactions
Infections
Nonsteroidal anti-inflammatory drugs (NSAIDs) may mask signs of infections such as fever and pain. This may delay the start of appropriate treatment for the infection, leading to a higher risk of complications. If you take this medication while having an infection and your symptoms persist or worsen, consult your doctor or pharmacist without delay
Follow exactly the medication administration instructions contained in this leaflet or those indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
The recommended dose is: Adults and adolescents over 12 years:
Take 1 tablet every 3-6 hours as needed.
Do not take more than 5 tablets in 24 hours.
Use in children:
Children under 12 years cannot take this medication.
These tablets are only for short treatments.
Take the minimum amount of tablets you need for the shortest period of time necessary to relieve your symptoms.You should use the most effective dose for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor or pharmacist without delay if symptoms (such as fever and pain) persist or worsen (see section 2).
Do not take Lizifen for more than 3 days,unless your doctor recommends it. If you do not improve, if you worsen, or if new symptoms appear, consult your doctor or pharmacist.
If you take more Lizifen than you should
In case of overdose or accidental ingestion, consult a doctor or pharmacist or go to the nearest hospital. You can also call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the amount taken. Overdose symptoms may include the following: nausea or vomiting, stomach pain or, less frequently, diarrhea. You may also experience ringing in the ears, headache, and gastrointestinal bleeding.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
STOP TAKING this medicine and consult your doctor immediately if you develop:
Inform your doctor or pharmacist if you observe any of the following effects or any effect not described in this leaflet:
The following side effects may occur:
Common(may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people)
Unknown frequency(cannot be estimated from available data)
Reporting of adverse reactions
If you experience any type of adverse reaction, consult your doctor or pharmacist, even if it is an adverse reaction that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use (www.notificaram.es). By reporting adverse reactions, you can contribute to providing more information on the safety of this medicine.
Keep out of sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and unused medicines. This will help protect the environment.
Do not store above 86°F (30°C).
Composition of Lizifen
The active ingredient is flurbiprofen. One tablet contains 8.75 mg of flurbiprofen.
The other components are:
Isomalta (E-953)
Maltitol (E-965)
Macrogol 300
Mint oil (contains d-limonene).
Lemon essence (contains d-limonene and geraniol).
Honey aroma
Appearance of the product and contents of the packaging
Round tablets, light to yellowish in color, with a diameter of 19±1 mm.
The tablets are available in PVC-PVDC/Aluminum blisters
Packaging size: 8, 12, 16, 20, 24 sucking tablets
Only some packaging sizes may be commercially available.
Marketing Authorization Holder
Opella Healthcare Spain, S.L.
C/ Rosselló i Porcel, 21
08016 Barcelona
Spain
Sanofi Group
Responsible for manufacturing
Lozy’s Pharmaceuticals, S.L.
Campus Empresarial s/n
31795 Lekaroz, Navarra
Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria:ratioDolor Flurbiprofen 8.75 mg Lozenges with Lemon Flavor
Spain:Lizifen 8.75 Sucking Tablets with Honey and Lemon Flavor
Portugal:Macifen Mel e Limão
You can access detailed and updated information about this medicine by scanning the QR code included in the prospectus and packaging with your smartphone.
You can also access this information at the following internet address:https://cima.aemps.es/cima/dochtml/p/81912/P_81912.html
Last review date of this prospectus:July 2022
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.